Description
Ebronucimab Biosimilar - Anti-PCSK9 mAb - Research Grade
Target
PCSK9
Target Alias Name
Ebronucimab/EBRONUCIMAB/ IMMUNOGLOBULIN G1/ ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL AK102 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL AK102 .LAMBDA.-CHAIN/ DIMER IMMUNOGLOBULIN G1-LAMBDA2/ ANTI-(HOMO SAPIENS PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9/ NEURAL APOPTOSIS-REGULATED CONVERTASE 1/ NARC1/ NARC-1/ PROPROTEIN CONVERTASE 9/ PC9))/ HOMO SAPIENS MONOCLONAL ANTIBODY/PCSK9/anti-PCSK10
Isotype/Mimetic
IgG1/Lambda
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression